DNA and genetic testing platform BIOguided is officially launching at the Clinical Cosmetic Regenerative Congress (CCR) 2026. The company says its genomics-led platform uses an individual’s DNA and genetic test results to analyse 45 genetic markers across 10 biological pathways. These include skin barrier function and sensitivity, oxidative stress, inflammation and inflammaging, collagen and extracellular matrix, pigmentation, glycation and metabolic ageing and injectable readiness.
BIOguided explains the platform then generates an individualised treatment protocol for each patient, spanning in-clinic treatments, homecare, supplements and broader wellness and sleep considerations.
Claire Williams, CEO and founder of BIOguided, shares, “For years, aesthetics has treated skin from the outside in and hoped for the best. If you aren’t testing, you are guessing. When you can see which pathways are driving someone’s skin ageing, you stop prescribing by trend and start prescribing by evidence supporting your patients unique biological signature and working on their skin and health longevity.”